CVC explores sale valuing Arthea at around $2 billion, sources say
CVC Capital Partners is exploring a sale of Arthea, the personal care platform behind Dr. Teal's, which sources say could value the platform at around $2 billion.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.